601 related articles for article (PubMed ID: 19853116)
1. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
[TBL] [Abstract][Full Text] [Related]
2. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
[TBL] [Abstract][Full Text] [Related]
5. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
8. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
9. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung.
Sayar A; Turna A; Kiliçgün A; Solak O; Urer N; Gürses A
Eur J Cardiothorac Surg; 2004 Mar; 25(3):434-8. PubMed ID: 15019674
[TBL] [Abstract][Full Text] [Related]
11. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer.
Nakagawa T; Okumura N; Kokado Y; Miyoshi K; Matsuoka T; Kameyama K
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):474-8. PubMed ID: 17669909
[TBL] [Abstract][Full Text] [Related]
12. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
14. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
15. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM
Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087
[TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment for stage III N2 non-small cell lung cancer].
Wang S; Wu Y; Rong T; Huang Z; Ou W
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):605-7. PubMed ID: 12667337
[TBL] [Abstract][Full Text] [Related]
17. [Significance of pulmonary lymph node metastases in locally advanced non-small cell lung cancer].
Marra A; Hillejan L; Pöttgen C; Zaboura G; Fechner S; Greschuchna D; Stamatis G
Pneumologie; 2002 Dec; 56(12):773-80. PubMed ID: 12486615
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
19. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
Watanabe S; Asamura H; Suzuki K; Tsuchiya R
Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
[TBL] [Abstract][Full Text] [Related]
20. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
